Indicated for the treatment of human sarcoptic scabies. Treatment is justified when the diagnosis of scabies has been established clinically and/or by parasitological examination. Without formal diagnosis treatment is not justified in case of pruritus.1
Official guidelines should be taken into consideration.
Adverse events should be reported. Healthcare professionals are asked to report any suspected adverse reactions via the Yellow Card Scheme https://yellowcard.mhra.gov.uk/ or search for MHRA Yellow Card in the Google Play or Apple App Store. Adverse events should also be reported to Exeltis UK Limited on 01494 411775 or by email to uk.medinfo@exeltis.com
| Pack size2 | 4 tablets |
| Price | £49.20 |
| PIP | 127-2541 |
| GTIN | 08436046011311 |
Ivermectin 3 mg Summary of Product Characteristics
BNF. Available at: https://bnf.nice.org.uk/drugs/ivermectin/medicinal-forms/ (Accessed October 2024)
Company info
